1 |
SARS-CoV |
Isatis tinctoria L. root extract |
53.80 μg/ml |
3CLpro
|
Lin et al. (2005)
|
2 |
SARS-CoV |
Indigo |
300.00 μM |
3CLpro
|
Lin et al. (2005)
|
3 |
SARS-CoV |
Sinigrin |
121.00 μM |
3CLpro
|
Lin et al. (2005)
|
4 |
SARS-CoV |
Aloe emodin |
132.00 μM |
3CLpro
|
Lin et al. (2005)
|
5 |
SARS-CoV |
Hesperetin |
60.00 μM |
3CLpro
|
Lin et al. (2005)
|
6 |
SARS-CoV |
Quercetin-3-β-galactoside |
42.79 μM |
3CLpro
|
Chen et al. (2006)
|
7 |
SARS-CoV |
18-Hydroxyferruginol |
45.80 μM |
3CLpro
|
Ryu et al. (2010a)
|
8 |
SARS-CoV |
Honokiol |
39.10 μM |
3CLpro
|
Ryu et al. (2010a)
|
9 |
SARS-CoV |
Ferruginol |
92.70 μM |
3CLpro
|
Ryu et al. (2010a)
|
10 |
SARS-CoV |
18-Oxoferruginol |
70.50 μM |
3CLpro
|
Ryu et al. (2010a)
|
11 |
SARS-CoV |
O-acetyl-18-hydroxyferruginol |
78.60 μM |
3CLpro
|
Ryu et al. (2010a)
|
12 |
SARS-CoV |
Methyl dehydroabietate |
46.70 μM |
3CLpro
|
Ryu et al. (2010a)
|
13 |
SARS-CoV |
Isopimaric acid |
28.90 μM |
3CLpro
|
Ryu et al. (2010a)
|
14 |
SARS-CoV |
Kayadiol |
75.20 μM |
3CLpro
|
Ryu et al. (2010a)
|
15 |
SARS-CoV |
Abietic acid |
58.00 μM |
3CLpro
|
Ryu et al. (2010a)
|
16 |
SARS-CoV |
Amentoflavone |
8.30 μM |
3CLpro
|
Ryu et al. (2010a)
|
17 |
SARS-CoV |
Bilobetin |
72.30 μM |
3CLpro
|
Ryu et al. (2010a)
|
18 |
SARS-CoV |
Ginkgetin |
32.00 μM |
3CLpro
|
Ryu et al. (2010a)
|
19 |
SARS-CoV |
Sciadopitysin |
38.40 μM |
3CLpro
|
Ryu et al. (2010a)
|
20 |
SARS-CoV |
Apigenin |
280.80 μM |
3CLpro
|
Ryu et al. (2010a)
|
21 |
SARS-CoV |
Luteolin |
20.20 μM |
3CLpro
|
Ryu et al. (2010a)
|
22 |
SARS-CoV |
Quercetin |
23.80 μM |
3CLpro
|
Ryu et al. (2010a)
|
22 |
SARS-CoV |
Quercetin |
73.00 μM |
3CLpro
|
Nguyen et al. (2012)
|
23 |
SARS-CoV |
Epigallocatechin gallate |
73.00 μM |
3CLpro
|
Nguyen et al. (2012)
|
24 |
SARS-CoV |
Gallocatechin gallate |
47.00 μM |
3CLpro
|
Nguyen et al. (2012)
|
25 |
SARS-CoV |
Tannic acid |
3.00 μM |
3CLpro
|
Chen et al. (2005)
|
26 |
SARS-CoV |
3-Isotheaflavin-3-gallate (TF2B) |
7.00 μM |
3CLpro
|
Chen et al. (2005)
|
27 |
SARS-CoV |
Theaflavin-3,3′-digallate (TF3) |
9.50 μM |
3CLpro
|
Chen et al. (2005)
|
28 |
SARS-CoV |
Betulinic acid |
10.00 μM |
3CLpro
|
Wen et al. (2007)
|
29 |
SARS-CoV |
Savinin |
25.00 μM |
3CLpro
|
Wen et al. (2007)
|
30 |
SARS-CoV |
Curcumin |
40.00 μM |
3CLpro
|
Wen et al. (2007)
|
30 |
SARS-CoV |
Curcumin |
23.50 μM |
3CLpro
|
Ryu et al. (2010b)
|
31 |
SARS-CoV |
Celastrol |
10.30 μM |
3CLpro
|
Ryu et al. (2010b)
|
32 |
SARS-CoV |
Pristimererin |
5.50 μM |
3CLpro
|
Ryu et al. (2010b)
|
33 |
SARS-CoV |
Tingenone |
9.90 μM |
3CLpro
|
Ryu et al. (2010b)
|
34 |
SARS-CoV |
Iguesterin |
2.60 μM |
3CLpro
|
Ryu et al. (2010b)
|
35 |
SARS-CoV |
Rheum palmatum L. extract (RH121) |
13.76 μg/ml |
3CLpro
|
Luo et al. (2009)
|
36 |
SARS-CoV |
Herbacetin |
33.17 μM |
3CLpro
|
Jo et al. (2020)
|
37 |
SARS-CoV |
Rhoifolin |
27.45 μM |
3CLpro
|
Jo et al. (2020)
|
38 |
SARS-CoV |
Pectolinarin |
37.78 μM |
3CLpro
|
Jo et al. (2020)
|
36 |
MERS-CoV |
Herbacetin |
40.59 μM |
3CLpro
|
Jo et al. (2019)
|
39 |
MERS-CoV |
Isobavachalcone |
35.85 μM |
3CLpro
|
Jo et al. (2019)
|
40 |
MERS-CoV |
Quercetin-3-β-D-glucoside |
37.03 μM |
3CLpro
|
Jo et al. (2019)
|
41 |
MERS-CoV |
Helichrysetin |
67.04 μM |
3CLpro
|
Jo et al. (2019)
|
22 |
SARS-CoV-2 |
Quercetin |
Ki = 7.00 μM |
3CLpro
|
Abian et al. (2020)
|
42 |
SARS-CoV-2 |
Baicalin |
6.41 μM |
3CLpro
|
Su et al. (2020)
|
43 |
SARS-CoV-2 |
Baicalein |
0.94 μM |
3CLpro
|
Su et al. (2020)
|
44 |
SARS-CoV-2 |
Chlorogenic acid |
39.48 μM |
3CLpro
|
Su et al. (2020)
|
45 |
SARS-CoV-2 |
Scutellarein |
3.02 μM |
3CLpro
|
Su et al. (2020)
|
46 |
SARS-CoV-2 |
Forsythoside A |
3.18 μM |
3CLpro
|
Su et al. (2020)
|
47 |
SARS-CoV-2 |
Forsythoside B |
2.88 μM |
3CLpro
|
Su et al. (2020)
|
48 |
SARS-CoV-2 |
Forsythoside E |
6.88 μM |
3CLpro
|
Su et al. (2020)
|
49 |
SARS-CoV-2 |
Forsythoside H |
10.17 μM |
3CLpro
|
Su et al. (2020)
|
50 |
SARS-CoV-2 |
Forsythoside I |
5.47 μM |
3CLpro
|
Su et al. (2020)
|
51 |
SARS-CoV-2 |
Isoforsythiaside |
5.85 μM |
3CLpro
|
Su et al. (2020)
|
25 |
SARS-CoV-2 |
Tannic acid |
13.40 μM |
3CLpro
|
Wang et al. (2020)
|
25 |
SARS-CoV-2 |
Tannic acid |
2.10 μM |
3CLpro
|
Coelho et al. (2020)
|
52 |
SARS-CoV-2 |
Hematoporphyrin |
3.90 μM |
3CLpro
|
Coelho et al. (2020)
|
53 |
SARS-CoV-2 |
Andrographolide |
15.05 μM |
3CLpro
|
Shi et al. (2020)
|
54 |
SARS-CoV-2 |
Δ9-Tetrahydrocannabinol |
10.25 μM (antiviral activity) |
3CLpro
|
Raj et al. (2021)
|
55 |
SARS-CoV-2 |
Cannabidiol |
7.91 μM (antiviral activity) |
3CLpro
|
Raj et al. (2021)
|
56 |
SARS-CoV-2 |
Kaempferol |
34.46 μM (antiviral activity) |
3CLpro
|
Khan et al. (2021)
|
57 |
SARS-CoV |
Hirsutenone |
36.20 μM |
3CLpro
|
Park et al. (2012b)
|
4.10 μM |
PLpro
|
58 |
SARS-CoV |
Hirsutanonol |
105.60 μM |
3CLpro
|
Park et al. (2012b)
|
7.80 μM |
PLpro
|
59 |
SARS-CoV |
Oregonin |
129.50 μM |
3CLpro
|
Park et al. (2012b)
|
20.10 μM |
PLpro
|
60 |
SARS-CoV |
Rubranol |
144.60 μM |
3CLpro
|
Park et al. (2012b)
|
12.30 μM |
PLpro
|
61 |
SARS-CoV |
Rubranoside B |
105.30 μM |
3CLpro
|
Park et al. (2012b)
|
8.00 μM |
PLpro
|
62 |
SARS-CoV |
Rubranoside A |
102.10 μM |
3CLpro
|
Park et al. (2012b)
|
9.10 μM |
PLpro
|
30 |
SARS-CoV |
Curcumin |
5.70 μM |
PLpro
|
Park et al. (2012b)
|
63 |
SARS-CoV |
Tanshinone IIA |
89.10 μM |
3CLpro
|
Park et al. (2012c)
|
1.60 μM |
PLpro
|
64 |
SARS-CoV |
Tanshinone IIB |
24.80 μM |
3CLpro
|
Park et al. (2012c)
|
10.70 μM |
PLpro
|
65 |
SARS-CoV |
Methyl tanshinonate |
21.10 μM |
3CLpro
|
Park et al. (2012c)
|
9.20 μM |
PLpro
|
66 |
SARS-CoV |
Cryptotanshinone |
226.70 μM |
3CLpro
|
Park et al. (2012c)
|
0.80 μM |
PLpro
|
67 |
SARS-CoV |
Tanshinone I |
38.70 μM |
3CLpro
|
Park et al. (2012c)
|
8.80 μM |
PLpro
|
68 |
SARS-CoV |
Dihydrotanshinone I |
14.40 μM |
3CLpro
|
Park et al. (2012c)
|
4.90 μM |
PLpro
|
69 |
SARS-CoV |
Rosmariquinone |
21.10 μM |
3CLpro
|
Park et al. (2012c)
|
30.00 μM |
PLpro
|
70 |
SARS-CoV |
Isobavachalcone |
39.40 μM |
3CLpro
|
Park et al. (2016)
|
13.00 μM |
PLpro
|
71 |
SARS-CoV |
4-Hydroxyderricin |
81.40 μM |
3CLpro
|
Park et al. (2016)
|
26.00 μM |
PLpro
|
72 |
SARS-CoV |
Xanthoangelol |
38.40 μM |
3CLpro
|
Park et al. (2016)
|
11.70 μM |
PLpro
|
73 |
SARS-CoV |
Xanthoangelol F |
34.10 μM |
3CLpro
|
Park et al. (2016)
|
5.60 μM |
PLpro
|
74 |
SARS-CoV |
Xanthoangelol D |
26.60 μM |
3CLpro
|
Park et al. (2016)
|
19.30 μM |
PLpro
|
75 |
SARS-CoV |
Xanthoangelol E |
11.40 μM |
3CLpro
|
Park et al. (2016)
|
1.20 μM |
PLpro
|
76 |
SARS-CoV |
Xanthoangelol B |
22.20 μM |
3CLpro
|
Park et al. (2016)
|
11.70 μM |
PLpro
|
77 |
SARS-CoV |
Xanthoangelol G |
129.80 μM |
3CLpro
|
Park et al. (2016)
|
46.40 μM |
PLpro
|
78 |
SARS-CoV |
Xanthokeistal A |
44.10 μM |
3CLpro
|
Park et al. (2016)
|
21.10 μM |
PLpro
|
79 |
SARS-CoV |
Broussochalcone B |
57.80 μM |
3CLpro
|
Park et al. (2017)
|
11.60 μM |
PLpro
|
80 |
SARS-CoV |
Broussochalcone A |
88.10 μM |
3CLpro
|
Park et al. (2017)
|
9.20 μM |
PLpro
|
81 |
SARS-CoV |
4-Hydroxyisolonchocarpin |
202.70 μM |
3CLpro
|
Park et al. (2017)
|
35.40 μM |
PLpro
|
82 |
SARS-CoV |
Papyriflavonol A |
103.60 μM |
3CLpro
|
Park et al. (2017)
|
3.70 μM |
PLpro
|
83 |
SARS-CoV |
3’-(3-Methylbut-2-enyl)-3′,4,7-trihydroxyflavane |
30.20 μM |
3CLpro
|
Park et al. (2017)
|
35.80 μM |
PLpro
|
84 |
SARS-CoV |
Kazinol A |
84.80 μM |
3CLpro
|
Park et al. (2017)
|
66.20 μM |
PLpro
|
85 |
SARS-CoV |
Kazinol B |
233.30 μM |
3CLpro
|
Park et al. (2017)
|
31.40 μM |
PLpro
|
86 |
SARS-CoV |
Broussoflavan A |
92.40 μM |
3CLpro
|
Park et al. (2017)
|
30.40 μM |
PLpro
|
87 |
SARS-CoV |
Kazinol F |
43.30 μM |
3CLpro
|
Park et al. (2017)
|
27.80 μM |
PLpro
|
88 |
SARS-CoV |
Kazinol J |
64.20 μM |
3CLpro
|
Park et al. (2017)
|
15.20 μM |
PLpro
|
89 |
SARS-CoV |
Isoliquiritigenin |
61.90 μM |
3CLpro
|
Park et al. (2017)
|
24.60 μM |
PLpro
|
56 |
SARS-CoV |
Kaempferol |
116.30 μM |
3CLpro
|
Park et al. (2017)
|
16.30 μM |
PLpro
|
22 |
SARS-CoV |
Quercetin |
52.70 μM |
3CLpro
|
Park et al. (2017)
|
8.60 μM |
PLpro
|
6 |
SARS-CoV |
Quercetin-3-β-galactoside |
128.80 μM |
3CLpro
|
Park et al. (2017)
|
51.90 μM |
PLpro
|
90 |
SARS-CoV-2 |
Ginkgolic acid |
1.79 μM |
3CLpro
|
Chen et al. (2021)
|
16.30 μM |
PLpro
|
91 |
SARS-CoV-2 |
Anacardic acid |
2.07 μM |
3CLpro
|
Chen et al. (2021)
|
17.08 μM |
PLpro
|
92 |
SARS-CoV |
N-trans-caffeoyltyramine |
44.40 μM |
PLpro
|
Song et al. (2014)
|
93 |
SARS-CoV |
N-trans-coumaroyltyramine |
38.80 μM |
PLpro
|
Song et al. (2014)
|
94 |
SARS-CoV |
N-trans-feruloyltyramine |
70.10 μM |
PLpro
|
Song et al. (2014)
|
95 |
SARS-CoV |
Terrestriamide |
21.50 μM |
PLpro
|
Song et al. (2014)
|
96 |
SARS-CoV |
N-trans-feruloyloctopamine |
26.60 μM |
PLpro
|
Song et al. (2014)
|
97 |
SARS-CoV |
Terrestrimine |
15.80 μM |
PLpro
|
Song et al. (2014)
|
98 |
SARS-CoV |
Tomentin A |
6.20 μM |
PLpro
|
Cho et al. (2013)
|
99 |
SARS-CoV |
Tomentin B |
6.10 μM |
PLpro
|
Cho et al. (2013)
|
100 |
SARS-CoV |
Tomentin C |
11.60 μM |
PLpro
|
Cho et al. (2013)
|
101 |
SARS-CoV |
Tomentin D |
12.50 μM |
PLpro
|
Cho et al. (2013)
|
102 |
SARS-CoV |
Tomentin E |
5.00 μM |
PLpro
|
Cho et al. (2013)
|
103 |
SARS-CoV |
3′-O-methyldiplacol |
9.50 μM |
PLpro
|
Cho et al. (2013)
|
104 |
SARS-CoV |
4′-O-methyldiplacol |
9.20 μM |
PLpro
|
Cho et al. (2013)
|
105 |
SARS-CoV |
3′-O-methyldiplacone |
13.20 μM |
PLpro
|
Cho et al. (2013)
|
106 |
SARS-CoV |
4′-O-methyldiplacone |
12.70 μM |
PLpro
|
Cho et al. (2013)
|
107 |
SARS-CoV |
Mimulone |
14.40 μM |
PLpro
|
Cho et al. (2013)
|
108 |
SARS-CoV |
Diplacone |
10.40 μM |
PLpro
|
Cho et al. (2013)
|
109 |
SARS-CoV |
6-Geranyl-4′,5,7-trihydroxy-3′,5′-dimethoxyflavanone |
13.90 μM |
PLpro
|
Cho et al. (2013)
|
110 |
SARS-CoV |
Bavachinin |
38.40 μM |
PLpro
|
Kim et al. (2014)
|
111 |
SARS-CoV |
Neobavaisoflavone |
18.30 μM |
PLpro
|
Kim et al. (2014)
|
112 |
SARS-CoV |
Isobavachalcone |
7.30 μM |
PLpro
|
Kim et al. (2014)
|
113 |
SARS-CoV |
4′-O-methylbavachalcone |
10.10 μM |
PLpro
|
Kim et al. (2014)
|
114 |
SARS-CoV |
Psoralidin |
4.20 μM |
PLpro
|
Kim et al. (2014)
|
115 |
SARS-CoV |
Corylifol A |
32.20 μM |
PLpro
|
Kim et al. (2014)
|
116 |
SARS-CoV |
Kwan du Bu Fei Dang exact |
471.30 μg/ml |
RdRp |
Fung et al. (2011)
|
117 |
SARS-CoV |
Houttuynia cordata exact |
251.10 μg/ml |
RdRp |
Fung et al. (2011)
|
118 |
SARS-CoV |
Ganoderma lucidum exact |
41.90 μg/ml |
RdRp |
Fung et al. (2011)
|
119 |
SARS-CoV |
Coriolus versicolor exact |
108.40 μg/ml |
RdRp |
Fung et al. (2011)
|
120 |
SARS-CoV |
Sinomenium acutum exact |
198.60 μg/ml |
RdRp |
Fung et al. (2011)
|
22 |
SARS-CoV |
Quercetin |
8.10 μM |
NTPase/helicase |
Lee et al. (2009b)
|
121 |
SARS-CoV |
Myricetin |
2.71 μM |
NTPase/helicase |
Yu et al. (2012)
|
122 |
SARS-CoV |
Scutellarein |
0.86 μM |
NTPase/helicase |
Yu et al. (2012)
|
123 |
SARS-CoV |
Tetra-O-galloyl-β-d-glucose (TGG) |
4.50 μM (antiviral activity) |
S protein |
Yi et al. (2004)
|
21 |
SARS-CoV |
Luteolin |
10.60 μM (antiviral activity) |
S protein |
Yi et al. (2004)
|
124 |
SARS-CoV |
Emodin |
200.00 μM |
S protein |
Ho et al. (2007)
|
125 |
SARS-CoV |
Griffithsin |
48–94 nM (antiviral activity) |
S protein |
O'Keefe et al. (2010)
|
126 |
SARS-CoV |
Urtica dioica L. agglutinin (UDA) |
0.60–2.60 μg/ml (antiviral activity) |
S protein |
Kumaki et al. (2011)
|
127 |
SARS-CoV-2 |
Kobophenol A |
1.81 μM |
S protein |
Gangadevi et al. (2021)
|
128 |
SARS-CoV |
(-)-Catechin gallate |
0.05 μg/ml |
N protein |
Roh (2012)
|
24 |
SARS-CoV |
(-)-Gallocatechin gallate |
0.05 μg/ml |
N protein |
Roh (2012)
|